Vaccines Market Research Reports & Industry Analysis

Competitor Analysis: Flavivirus Vaccines: Zika, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis & Tick-Borne Encephalitis Virus Vaccines The Competitive Intelligence Report Flavivirus Vaccines: Zika, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis & Tick-Borne Encephalitis Virus Vaccines“ provides a competitor ...

This report analyzes the worldwide markets for Prophylactic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines, and Adult Prophylactic Vaccines. The report provides separate ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

Competitor Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines The Competitive Intelligence Report Amyloid beta- and Tau-Targeted Antibodies & Vaccines as of September 2015 provides a competitor analysis in the ... , the report lists company-specific R&D pipelines of amyloid beta- and tau-targeted antibodies & vaccines. Competitor projects are listed in a tabular format providing Information ...

... cancer vaccines will hit the shelf in coming years. “Global Cancer Vaccine Market & Clinical Trial Insight” Report Highlights: Global Cancer Market Overview Emergence of Personalized Cancer Vaccines Platforms for Cancer Vaccines Delivery Mechanism of Cancer Vaccines Global Cancer Vaccines Clinical ...

... China policy environment and government purchase of FMD vaccine in China supply of and demand for FMD vaccine in China major producers of FMD vaccine and their operation status in China factors affecting development of FMD vaccine in China expectation to FMD vaccine industry in China ...

... Measles, Mumps & Rubella (MMR) Vaccines 2. Haemophilus Influenzae Type B (HIB) Vaccines 3. Polio Vaccines 4. Diphtheria Tetanus & Pertussis (DTaP) Vaccines 5. Pneumococcal Vaccines 6. Rotavirus Vaccines 7. Hepatitis B Pediatric Vaccines 8. Hepatitis A Pediatric Vaccines 9. Varicella / Chicken Pox Vaccines ...

... vaccines, there has been more disease reduction in both vaccinated and unvaccinated populations. As vaccines evolve, similar improvements can be expected. According to our report, “Global Pneumonia Vaccine Market Outlook 2020”, the Pneumonia vaccine market for 2014, which ...

... Cancer Vaccine Clinical Pipeline by Company, Indication & Phase US Cancer Vaccine Clinical Pipeline: 187 Vaccines Clinical Insight of Marketed Cancer Vaccines in US Marketed Cancer Vaccine in US: 5 Vaccines FDA Regulations for Clinical Trials of Cancer Vaccines Clinical Insight of Marketed Cancer Vaccines ...

... Introduction to HIV Vaccines Issues Related to the Development of HIV Vaccines Parameters for Successful Commercialization of HIV Vaccines Global HIV Vaccines Market Opportunity Analysis Global HIV Vaccine Clinical Pipeline by Company & Phase Global HIV Vaccine Clinical Pipeline: 100 Vaccines Majority Vaccine ...

... Pneumococcal vaccines (PCV) and Varicella vaccines are the leading market share holder in Canada and together they contribute more than 50% of the total Pediatric vaccines market. Polio, Measles, Mumps & Rubella (MMR), Diphtheria, Tetanus & Pertussis (DTaP ...

... registration for meningococcal polysaccharide vaccine (Group A/C/Y/W 135) and other vaccines in Nigeria, Chile, Peru, Thailand, and India. China Human Vaccine Industry Report, 2015-2018 highlights the following: Operating environment, overall situation, sales channel, etc. of China human vaccine industry; Supply & demand ...

... Lung Cancer Vaccine Global Lung Cancer Vaccine Market Analysis Global Lung Cancer Vaccine Pipeline by Company & Phase Global Lung Cancer Vaccine Pipeline: 29 Vaccines Majority Lung Cancer Vaccines in Phase-II: 8 Vaccines Marketed Lung Cancer Vaccines: 3 ( BV NSCLC 001, Mycidac-C & Vaxira) Personalized Cancer ...

... Skin Cancer Vaccine Global Skin Cancer Vaccine Market Analysis Global Skin Cancer Vaccine Pipeline by Company & Phase Global Skin Cancer Vaccine Pipeline: 47 Vaccines Majority Skin Cancer Vaccines in Phase-I: 12 Vaccines Marketed Skin Cancer Vaccines ...

This report analyzes the worldwide markets for H1N1 Vaccines in US$ Million. The report provides separate comprehensive analytics for the US, ... 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

... Global Peptide Vaccine Market & Pipeline Insight” Report Highlights: Introduction & Mechanism of Peptide Vaccine Peptide Vaccine Market Overview Peptide Vaccine Market Dynamics (Drivers, Challenges & Future Outlook) Peptide Vaccine Pipeline by Phase, Indication, Company & Country Peptide Vaccine Pipeline ...

... main drivers to galvanized Influenza vaccines market. Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow ... digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and ...

Competitor Analysis: Ebola Virus Vaccines and Therapeutics The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections ... Ebola virus infections as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...

... Ebola Virus Vaccine Market & Pipeline Insight” Report Highlight: Ebola Virus Infection Market Overview Ebola Vaccine Clinical Trial Insight by Phase, Company & Country Ebola Vaccine in Clinical Trials: 26 Vaccine Majority Ebola Vaccine in Preclinical Phase: 15 Vaccines Ebola Vaccines ...

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins The present Competitive Intelligence Report about prophylaxis and therapy of Rabies ... virus infections as of September 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...

... Cancer Vaccines Delivery Cancer Vaccines: Mechanism & Innovations Global Cancer Vaccines Clinical Pipeline by Phase, Indication, Company & Country Global Cancer Vaccine Clinical Pipeline: 289 Vaccines Marketed Cancer Vaccines: 12 Vaccines Regulatory Framework for Cancer Vaccines Development & Marketing ...

... (PPV) and other varieties. Since 2011, the bids for compulsory vaccines proposed by the Chinese government has turned to be more fierce, with ... Group, Tecon and Dahuanong with a combined proportion of 15% or so. China Animal Vaccine Industry Report, 2013-2016 by ResearchInChina covers the followings: The ...

... could thus be used as a basis of the vaccine. There are only 2 HPV vaccines which are currently marketed across the globe. Both ... to treat it, either through drugs or through vaccines. “Human Papillomavirus Infections Vaccine Pipeline Analysis” Report Highlights: Human Papillomavirus Vaccine Market Overview ...

... activities and generic competition for off patent products. On the contrary, vaccine segment has developed as highly profitable because of advancements in genomics and ... sales, which thereby allure the market players. The report, “Global Vaccine Market Outlook 2020” provides an extensive research and in-depth ...

... “Global Influenza (Flu) Vaccine Market: Trends and Opportunities (2014-2019)” provides an insight into the market dynamics and various trends and opportunities associated with the global Influenza vaccine market. It covers the global market size and growth dynamics of the influenza vaccine market in past ...

... lines), microorganism-based and others. Of the 140 clinical stage cancer vaccines, three were approved and are commercialized in the major ... . In addition, the report lists company-specific R&D pipelines of cancer vaccines. Competitor projects are listed in a tabular format providing information on: Drug ...

... promising. “HIV Vaccine Market Opportunity & Clinical Pipeline Analysis” Report Highlights: Introduction to HIV Vaccine & Mechanism Global HIV Incidence Scenario R&D Funding Scenario for HIV Vaccine FDA Regulatory Framework HIV Vaccine Clinical Trial by Phase & Country HIV Vaccines in Development Phase ...

... for entry. Constituting almost 50% of the global pie, the US cancer vaccine market was estimated to be worth USD 14 Billion in 2012. With close ... cancer every year, this market is expected to o reach USD 20 billion by 2020. “US Cancer Vaccine Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...

... sub-divided into four groups namely, pediatrics, adolescents, adults and elderly. Though the vaccines segment forms a very small portion of the ... market is expected to surpass estimated USD 100 billion by 2025. “Global Vaccine Market Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ...

... , proteins, peptides, vaccines and small molecules for prevention and treatment of Staphylococcus aureus infections. In addition, the report lists company-specific R&D pipelines of S. aureus vaccines and therapeutics. Competitor projects are listed in a tabular format providing information on: Drug ...

... West Nile Virus to be used in horses was approved in 2005. 'Global DNA Vaccine Pipeline Analysis' by PNS Pharma gives comprehensive insight on the various ... holders to identify and analyze the available investment opportunity in the DNA vaccine market based upon development process. Following parameters for ...

... (incidence rate: below 1/100,000,000). In 2012, China's lot released volume of measles vaccines reached 8.651 million person-servings, decreasing ... vaccines manufactured by Merck violated the approval process of imported vaccines in China because it lacked alerts in the specification and existed safety risks. ...

... , but the rabies vaccination rate of dogs is less than 10%. Second, China lacks a coordination and management mechanism among departments involving in rabies ... the following information or even more: Development environment of China human rabies vaccines China rabies status overview Supply and demand status ...

... influenza type B is a kind of haemophilus influenza with extremely strong invasiveness. Among all the serious infections caused by haemophilus influenzas, almost 90% were caused by haemophilus influenza type B. According to the researches in recent years, HIB has become the first bacteria that will cause ...

... Type B Haemophilus Influenzae Conjugate Vaccine, Influenza Vaccine, Rabies Vaccine and so on. In China, Vaccine I market are occupied by state-owned enterprises, while foreign- ... market will rise continually. Due to the low vaccination rate in China, there's much space for future growth. With the increase of ...

The Competitive Intelligence Report Anthrax Vaccines & Therapeutics as of June 2013 provides a competitor analysis in the development pipelines of novel vaccines and therapeutics for prophylaxis of Bacillus anthracis infection and treatment of anthrax. Purchase of the pdf report includes a 6-month online ...

... perspective on the actual market situation, trends and future outlook for vaccines in Ireland. The study provides essential market information for decision- ... market study answers to questions such as: What is the size of the vaccine market in Ireland? How is the market divided into different types of products ...

... perspective on the actual market situation, trends and future outlook for vaccines in Panama. The study provides essential market information for decision- ... market study answers to questions such as: What is the size of the vaccine market in Panama? How is the market divided into different types of products? ...

... as: What is the size of the vaccine markets in different countries around the world? How are the markets divided into different types ... Years covered: 2006 - 2017 Countries included in the package: Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belgium, Bolivia, Bulgaria, Canada, Chile, ...

... a perspective on the actual market situation, trends and future outlook for vaccines in Mongolia. The study provides essential market information for decision- ... study answers to questions such as: What is the size of the vaccine market in Mongolia? How is the market divided into different types of products? ...

... a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market ... These market studies answer to questions such as: What is the size of the vaccine markets in top 10 global countries? How are the markets divided into ...

... indicators This market study answers to questions such as: What is the size of the global vaccine market? How is the market divided into different types of products? Which products are growing fast? How the market has been developing? How does the future look like? What is the ...

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different American countries. The studies ... different types of products? Which products are growing fast? How the markets have been developing? How does the future look like? ...

The Competitive Intelligence Report Human Papilloma Virus (HPV) Vaccines & Therapeutics as of May 2013 provides a competitor analysis in the product portfolios and development pipelines of novel vaccines and therapeutics for prophylaxis of HPV infection and HPV-induced neoplasias and treatment of HPV-induced ...

... and operating incomes amidst patent cliffs of blockbuster drugs. In such a scenario, vaccines, which have high entry barriers for generic players and ... with high incidence rates of infectious diseases. The report, “Global Vaccine Market Forecast to 2017” provides an extensive research and in-depth analysis ...

... global management consulting and market research firm, has conducted a competitive analysis of the industry and presents its findings in Global Human Vaccine Industry 2013-2018: Trend, Profit, and Forecast Analysis. North America dominates this industry. India and China are rapidly growing as vaccine production ...

... infect humans. HSV-1 and HSV-2 cause the viral disease herpes simplex which can be categorized into one of several distinct disorders ... . In addition, the report lists company-specific R&D pipelines of Herpes Virus Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information ...

... Indian Vaccine Industry: Trends and Opportunities (2012-2017) offers in-depth study of the global as well as the Indian vaccine industry with detailed discussion on the major segments of the vaccine industry ...

... , Company, Product Category, Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, ...

... targeting Mycobacterium tuberculosis for prophylaxis and treatment of tuberculosis. In addition, the report lists corporate and public R&D pipelines of Tuberculosis Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action ...

... description The present Competitive Intelligence Report about Malaria Vaccines & Therapeutics provides a competitor evaluation in the field of investigational small molecules and ... regions. Each year more than 350 million new cases of Malaria occur, it is one of the world’s most common diseases. People with ...